Back to Top
Torudokimab Biosimilar - Research Grade
$710.00 - $19,500.00
Torudokimab Biosimilar - Research Grade
Endotoxin
≤ 1.0 EU/mg as determined by the LAL method
Purity
>95% by SDS-PAGE
Species Reactivity
Human
Target
IL33
Concentration
5mg/ml
Isotype
Human IgG4 - kappa
Host
CHO Cells
Sequence
https://www.imgt.org/mAb-DB/
Buffer
ICH2988
Uniprot
O95760
Shipping Conditions
Blue ice
Background
Interleukin-33 (IL33) is an alarmin cytokine released upon tissue damage that drives type 2 immunity and is widely studied in asthma, fibrosis, and inflammation. Our research-grade anti-human IL33 recombinant monoclonal antibody is an unconjugated, non-therapeutic analog of torudokimab for research use only (RUO). Manufactured to in vivo standards and purified to low endotoxin, it is available in scalable milligram (mg) to gram (g) quantities for heavy-usage and high-throughput laboratories. It is suited to cytokine neutralization assays, in vitro functional screening, and in vivo models of allergic and inflammatory disease as a reproducible reagent.
Specificity
Detects human IL33
Purification Method
This monoclonal antibody was purified using Protein A
Formulation
Sterile, preservative-free, solution in PBS. BSA and Azide free.
Storage
This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Applications
Functional Assays
Application Notes
This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.
Use
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Delivery Time
4 weeks
Write Your Own Review













